Tidal Investments LLC raised its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) by 7.9% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,664 shares of the company’s stock after buying an additional 340 shares during the period. Tidal Investments LLC’s holdings in Acadia Healthcare were worth $296,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds also recently modified their holdings of ACHC. State Street Corp lifted its stake in Acadia Healthcare by 3.5% during the third quarter. State Street Corp now owns 2,819,911 shares of the company’s stock valued at $178,811,000 after buying an additional 95,613 shares in the last quarter. Principal Financial Group Inc. raised its position in Acadia Healthcare by 19.4% during the second quarter. Principal Financial Group Inc. now owns 643,521 shares of the company’s stock valued at $43,463,000 after buying an additional 104,359 shares during the period. LMR Partners LLP acquired a new stake in Acadia Healthcare during the 3rd quarter worth about $1,616,000. Texas Permanent School Fund Corp grew its stake in Acadia Healthcare by 11.3% during the 2nd quarter. Texas Permanent School Fund Corp now owns 89,821 shares of the company’s stock valued at $6,067,000 after acquiring an additional 9,115 shares in the last quarter. Finally, Sivik Global Healthcare LLC increased its holdings in shares of Acadia Healthcare by 43.7% in the 3rd quarter. Sivik Global Healthcare LLC now owns 115,000 shares of the company’s stock valued at $7,292,000 after purchasing an additional 34,997 shares during the period.
Wall Street Analyst Weigh In
A number of research analysts recently commented on ACHC shares. StockNews.com raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Thursday, December 19th. KeyCorp started coverage on Acadia Healthcare in a report on Friday, October 11th. They set a “sector weight” rating for the company. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their target price for the company from $45.00 to $75.00 in a research note on Thursday, December 12th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $52.00 target price on shares of Acadia Healthcare in a research report on Tuesday, December 10th. Finally, Royal Bank of Canada dropped their price target on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating on the stock in a research report on Monday, November 18th. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $75.44.
Acadia Healthcare Price Performance
Shares of ACHC stock opened at $37.67 on Wednesday. The company has a market capitalization of $3.50 billion, a P/E ratio of 12.35, a P/E/G ratio of 1.77 and a beta of 1.30. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare Company, Inc. has a 12 month low of $36.50 and a 12 month high of $87.77. The stock has a 50 day moving average of $43.03 and a two-hundred day moving average of $60.27.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. The firm had revenue of $815.60 million for the quarter, compared to the consensus estimate of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business’s revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.91 earnings per share. As a group, equities analysts expect that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.
About Acadia Healthcare
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
See Also
- Five stocks we like better than Acadia Healthcare
- Why Are Stock Sectors Important to Successful Investing?
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- The How and Why of Investing in Gold Stocks
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.